Skip to content
All Sections
Subscribe Now
80°F
Wednesday, July 24th 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
80°F
Wednesday, July 24th 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
Biden drops out of race
Project 2025's impact in CA
Homeless pet food pantry opens
SpaceX moving to Texas
LB Burger Week ð
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Panbela Therapeutics Inc
(NQ:
PBLA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.020 (5)
Ask (Size)
1.040 (1)
Prev. Close
1.110
Today's Range
N/A - N/A
52wk Range
1.060 - 43.40
Shares Outstanding
5,127,686
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024
May 15, 2024
PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
May 06, 2024
Developed in collaboration with Sanofi.
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Performance
More News
Read More
Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024
May 01, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Recap: Panbela Therapeutics Q4 Earnings
March 26, 2024
Via
Benzinga
Earnings Preview: Panbela Therapeutics
March 25, 2024
Via
Benzinga
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
April 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
April 22, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Poster Presentation at American Association for Cancer Research:
April 18, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Panbela Announces Transfer to OTCQB Market
April 16, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
March 12, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Top 4 Health Care Stocks That Are Preparing To Pump This Month
February 23, 2024
Via
Benzinga
Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
February 15, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Secures ~$9M in Public Offering
February 01, 2024
Via
Investor Brand Network
Panbela Announces Closing of Approximately $9.0 Million Public Offering
February 01, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
What's Going On With Panbela Therapeutics Stock Today?
January 30, 2024
Via
Benzinga
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
January 30, 2024
From
Panbela Therapeutics, Inc.
Via
GlobeNewswire
Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 29, 2024
Via
Benzinga
Dow Edges Lower; Cardlytics Shares Jump
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal
January 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Aclarion (ACON) Stock Down 16% Today?
January 29, 2024
Via
InvestorPlace
Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today?
January 29, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close